# OnCo record jounce-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/jounce-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "jounce-therapeutics" ;
  schema:name "Jounce Therapeutics"@en ;
  schema:alternateName "Jounce Therapeutics, Inc."@en ;
  schema:description "Jounce Therapeutics developed treatments that help the immune system attack cancer, along with tests to predict who would benefit. Concentra Biosciences bought it in 2023."@en ;
  schema:url <https://onco.cc/companies/jounce-therapeutics/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1640455/000164045523000084/jnce-exhibit991.htm>, <https://www.thirdrockventures.com/portfolio/jounce> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> .